American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity


American Health Packaging has voluntarily recalled eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters to the consumer level due to the potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. (US Food Recalls) More More

Similar stories

Recon: FDA Approves Biohaven Migraine Drug; WHO Says Global Risk of Coronavirus is 'Very High' - Regulatory Focus

Recon: FDA Approves Biohaven Migraine Drug; WHO Says Global Risk of Coronavirus is 'Very High'  Regulatory Focus

Posted on 28 February 2020 | 3:00 am | Google News

American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity - FDA.gov

American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity  FDA.gov

Posted on 27 February 2020 | 3:00 am | Google News

Food Recall Warning (norovirus) – Certain Union Bay Seafood Ltd. brand Pacific Oysters - Food Poisoning News

Food Recall Warning (norovirus) – Certain Union Bay Seafood Ltd. brand Pacific Oysters  Food Poisoning News

Posted on 26 February 2020 | 3:00 am | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info